Replicel Life Sciences Stock Fundamentals
| RP Stock | CAD 0.06 0.00 0.00% |
RepliCel Life Sciences fundamentals help investors to digest information that contributes to RepliCel Life's financial success or failures. It also enables traders to predict the movement of RepliCel Stock. The fundamental analysis module provides a way to measure RepliCel Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RepliCel Life stock.
At this time, RepliCel Life's Interest Expense is fairly stable compared to the past year. Other Operating Expenses is likely to climb to about 2.7 M in 2024, whereas Operating Income is likely to drop (1.5 M) in 2024. RepliCel | Select Account or Indicator |
RepliCel Life Sciences Company Return On Asset Analysis
RepliCel Life's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current RepliCel Life Return On Asset | -1.02 |
Most of RepliCel Life's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RepliCel Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
RepliCel Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for RepliCel Life is extremely important. It helps to project a fair market value of RepliCel Stock properly, considering its historical fundamentals such as Return On Asset. Since RepliCel Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RepliCel Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RepliCel Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
RepliCel Total Assets
Total Assets |
|
Based on the latest financial disclosure, RepliCel Life Sciences has a Return On Asset of -1.0197. This is 88.35% lower than that of the Biotechnology sector and 95.68% lower than that of the Health Care industry. The return on asset for all Canada stocks is notably higher than that of the company.
RepliCel Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RepliCel Life's current stock value. Our valuation model uses many indicators to compare RepliCel Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RepliCel Life competition to find correlations between indicators driving RepliCel Life's intrinsic value. More Info.RepliCel Life Sciences is currently regarded as top stock in return on asset category among its peers. It also is currently regarded as top stock in profit margin category among its peers . At this time, RepliCel Life's Net Loss is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RepliCel Life's earnings, one of the primary drivers of an investment's value.RepliCel Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RepliCel Life's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RepliCel Life could also be used in its relative valuation, which is a method of valuing RepliCel Life by comparing valuation metrics of similar companies.RepliCel Life is currently under evaluation in return on asset category among its peers.
RepliCel Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of RepliCel Life from analyzing RepliCel Life's financial statements. These drivers represent accounts that assess RepliCel Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of RepliCel Life's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.1M | 6.2M | 7.5M | 3.2M | 3.9M | 3.7M | |
| Enterprise Value | 6.6M | 6.2M | 7.3M | 2.8M | 4.6M | 8.4M |
RepliCel Fundamentals
| Return On Asset | -1.02 | ||||
| Profit Margin | 1.13 % | ||||
| Operating Margin | (1.43) % | ||||
| Current Valuation | 4.56 M | ||||
| Shares Outstanding | 65 M | ||||
| Shares Owned By Insiders | 62.69 % | ||||
| Number Of Shares Shorted | 869 | ||||
| Price To Earning | (1.05) X | ||||
| Price To Sales | 10.11 X | ||||
| Revenue | 353.74 K | ||||
| Gross Profit | 353.74 K | ||||
| EBITDA | (1.38 M) | ||||
| Net Income | (311.73 K) | ||||
| Cash And Equivalents | 1.16 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 813.19 K | ||||
| Current Ratio | 2.09 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (1.41 M) | ||||
| Short Ratio | 0.13 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 1.64 | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 3.58 M | ||||
| Total Asset | 287.79 K | ||||
| Retained Earnings | (43.29 M) | ||||
| Working Capital | (1.44 M) | ||||
| Net Asset | 287.79 K |
About RepliCel Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RepliCel Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RepliCel Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RepliCel Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 406.8 K | 370.6 K | |
| Cost Of Revenue | 1.3 K | 1.3 K | |
| Total Revenue | 318.4 K | 437.1 K | |
| Stock Based Compensation To Revenue | 0.18 | 0.27 | |
| Sales General And Administrative To Revenue | 3.66 | 5.74 | |
| Research And Ddevelopement To Revenue | 1.49 | 1.41 | |
| Revenue Per Share | 0.01 | 0.01 | |
| Ebit Per Revenue | (3.92) | (4.11) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.